Advertisement

Index by author

January 01, 1980; Volume 8,Issue 1

A

  1. Al-Turk, W A

    1. Altered metabolism of 7-ethoxycoumarin by hepatic, pulmonary, and intestinal microsomes from streptozotocin-diabetic rats.
      W A Al-Turk, S J Stohs and E B Roche
      Drug Metabolism and Disposition January 1980, 8 (1) 44-45;

B

  1. Brilis, G M

    1. A major pathway of mephenytoin metabolism in man. Aromatic hydroxylation to p-hydroxymephenytoin.
      A Küpfer, G M Brilis, J T Watson and T M Harris
      Drug Metabolism and Disposition January 1980, 8 (1) 1-4;

C

  1. Campbell, S

    1. Disposition of all-trans- and 13-cis-retinoic acids and n-hydroxyethylretinamide in mice after intravenous administration.
      C C Wang, S Campbell, R L Furner and D L Hill
      Drug Metabolism and Disposition January 1980, 8 (1) 8-11;

  2. Carter, D E

    1. Isolation and identification of the polar metabolites of chlorpheniramine in the dog.
      J D Osterloh, A Karakaya and D E Carter
      Drug Metabolism and Disposition January 1980, 8 (1) 12-15;

  3. Chhabra, R S

    1. Factors affecting the properties of mixed-function oxidases in the liver and small intestine of neonatal rabbits.
      J M Tredger and R S Chhabra
      Drug Metabolism and Disposition January 1980, 8 (1) 16-22;

  4. Curtis, L R

    1. Specificity of chlordecone-induced potentiation of carbon tetrachloride hepatotoxicity.
      L R Curtis and H M Mehendale
      Drug Metabolism and Disposition January 1980, 8 (1) 23-27;

D

  1. Daniel, F B

    1. Oxidative metabolites of 7,12-dimethylbenz[a]anthracene. Further investigation of the K-region epoxide.
      L K Wong, C L Wang and F B Daniel
      Drug Metabolism and Disposition January 1980, 8 (1) 28-33;

E

  1. El Dareer, S M

    1. Metabolism and disposition of erythro-9-(2-hydroxy-3-nonyl)[14C]adenine in the rhesus monkey.
      W R McConnell, S M El Dareer and D L Hill
      Drug Metabolism and Disposition January 1980, 8 (1) 5-7;

F

  1. Furner, R L

    1. Disposition of all-trans- and 13-cis-retinoic acids and n-hydroxyethylretinamide in mice after intravenous administration.
      C C Wang, S Campbell, R L Furner and D L Hill
      Drug Metabolism and Disposition January 1980, 8 (1) 8-11;

G

  1. Gillette, J R

    1. Metabolite pharmacokinetics: methods for simultaneous estimates of elimination rate constants of a drug and its metabolite. A commentary.
      K S Pang and J R Gillette
      Drug Metabolism and Disposition January 1980, 8 (1) 39-43;

  2. Guengerich, F P

    1. Metabolic activation of model pyrroles by cytochrome P-450.
      F P Guengerich and M B Mitchell
      Drug Metabolism and Disposition January 1980, 8 (1) 34-38;

H

  1. Harris, T M

    1. A major pathway of mephenytoin metabolism in man. Aromatic hydroxylation to p-hydroxymephenytoin.
      A Küpfer, G M Brilis, J T Watson and T M Harris
      Drug Metabolism and Disposition January 1980, 8 (1) 1-4;

  2. Hill, D L

    1. Metabolism and disposition of erythro-9-(2-hydroxy-3-nonyl)[14C]adenine in the rhesus monkey.
      W R McConnell, S M El Dareer and D L Hill
      Drug Metabolism and Disposition January 1980, 8 (1) 5-7;
    2. Disposition of all-trans- and 13-cis-retinoic acids and n-hydroxyethylretinamide in mice after intravenous administration.
      C C Wang, S Campbell, R L Furner and D L Hill
      Drug Metabolism and Disposition January 1980, 8 (1) 8-11;

K

  1. Karakaya, A

    1. Isolation and identification of the polar metabolites of chlorpheniramine in the dog.
      J D Osterloh, A Karakaya and D E Carter
      Drug Metabolism and Disposition January 1980, 8 (1) 12-15;

  2. Küpfer, A

    1. A major pathway of mephenytoin metabolism in man. Aromatic hydroxylation to p-hydroxymephenytoin.
      A Küpfer, G M Brilis, J T Watson and T M Harris
      Drug Metabolism and Disposition January 1980, 8 (1) 1-4;

M

  1. McConnell, W R

    1. Metabolism and disposition of erythro-9-(2-hydroxy-3-nonyl)[14C]adenine in the rhesus monkey.
      W R McConnell, S M El Dareer and D L Hill
      Drug Metabolism and Disposition January 1980, 8 (1) 5-7;

  2. Mehendale, H M

    1. Specificity of chlordecone-induced potentiation of carbon tetrachloride hepatotoxicity.
      L R Curtis and H M Mehendale
      Drug Metabolism and Disposition January 1980, 8 (1) 23-27;

  3. Mitchell, M B

    1. Metabolic activation of model pyrroles by cytochrome P-450.
      F P Guengerich and M B Mitchell
      Drug Metabolism and Disposition January 1980, 8 (1) 34-38;

O

  1. Osterloh, J D

    1. Isolation and identification of the polar metabolites of chlorpheniramine in the dog.
      J D Osterloh, A Karakaya and D E Carter
      Drug Metabolism and Disposition January 1980, 8 (1) 12-15;

P

  1. Pang, K S

    1. Metabolite pharmacokinetics: methods for simultaneous estimates of elimination rate constants of a drug and its metabolite. A commentary.
      K S Pang and J R Gillette
      Drug Metabolism and Disposition January 1980, 8 (1) 39-43;

R

  1. Roche, E B

    1. Altered metabolism of 7-ethoxycoumarin by hepatic, pulmonary, and intestinal microsomes from streptozotocin-diabetic rats.
      W A Al-Turk, S J Stohs and E B Roche
      Drug Metabolism and Disposition January 1980, 8 (1) 44-45;

S

  1. Stohs, S J

    1. Altered metabolism of 7-ethoxycoumarin by hepatic, pulmonary, and intestinal microsomes from streptozotocin-diabetic rats.
      W A Al-Turk, S J Stohs and E B Roche
      Drug Metabolism and Disposition January 1980, 8 (1) 44-45;

T

  1. Tredger, J M

    1. Factors affecting the properties of mixed-function oxidases in the liver and small intestine of neonatal rabbits.
      J M Tredger and R S Chhabra
      Drug Metabolism and Disposition January 1980, 8 (1) 16-22;

W

  1. Wang, C C

    1. Disposition of all-trans- and 13-cis-retinoic acids and n-hydroxyethylretinamide in mice after intravenous administration.
      C C Wang, S Campbell, R L Furner and D L Hill
      Drug Metabolism and Disposition January 1980, 8 (1) 8-11;

  2. Wang, C L

    1. Oxidative metabolites of 7,12-dimethylbenz[a]anthracene. Further investigation of the K-region epoxide.
      L K Wong, C L Wang and F B Daniel
      Drug Metabolism and Disposition January 1980, 8 (1) 28-33;

  3. Watson, J T

    1. A major pathway of mephenytoin metabolism in man. Aromatic hydroxylation to p-hydroxymephenytoin.
      A Küpfer, G M Brilis, J T Watson and T M Harris
      Drug Metabolism and Disposition January 1980, 8 (1) 1-4;

  4. Wong, L K

    1. Oxidative metabolites of 7,12-dimethylbenz[a]anthracene. Further investigation of the K-region epoxide.
      L K Wong, C L Wang and F B Daniel
      Drug Metabolism and Disposition January 1980, 8 (1) 28-33;
Back to top

In this issue

Advertisement